<SEC-DOCUMENT>0001829126-22-016171-index.html : 20220825
<SEC-HEADER>0001829126-22-016171.hdr.sgml : 20220825
<ACCEPTANCE-DATETIME>20220825161937
ACCESSION NUMBER:		0001829126-22-016171
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220815
FILED AS OF DATE:		20220825
DATE AS OF CHANGE:		20220825

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			NATAN DAVID
		CENTRAL INDEX KEY:			0001253108

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13341
		FILM NUMBER:		221197624

	MAIL ADDRESS:	
		STREET 1:		11190 BISCAYNE BLVD
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33181

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TITAN PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000910267
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943171940
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		400 OYSTER POINT BLVD
		STREET 2:		SUITE 505
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		6502444990

	MAIL ADDRESS:	
		STREET 1:		400 OYSTER POINT BLVD
		STREET 2:		SUITE 505
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>3
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>